Multiple Myeloma Management app analytics for December 19
Multiple Myeloma Management
- UMA MLG, LLC
- Apple App Store
- Free
- Medical
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
Store Rank
The Store Rank is based on multiple parameters set by Google and Apple.
All Categories in
United States--
Medical in
United States--
Top Competitors & Alternative Apps
Apps with a high probability of being used by the same users, from the same store.
Multiple Myeloma Manager
![Multiple Myeloma [MM]](https://is1-ssl.mzstatic.com/image/thumb/Purple211/v4/1a/90/31/1a9031ae-a57a-c250-f5a7-5253b916308c/AppIcon-0-0-1x_U007epad-0-10-0-85-220.png/175x175bb.jpg){kind=small}
Multiple Myeloma [MM]
SurvivorNet
HealthTree
Multiple Myeloma Management VS. December 19, 2024